Sanofi
A Scientist at Vitry-sur-Seine, France, examining samples through a microscope in a laboratory with scientific equipment, a computer displaying cellular imagery, and purple data waves emanating from the microscope.

Nizar El Murr, Principal Scientist and Lab Head in immuno-oncology, Vitry-sur-Seine, France

Nizar El Murr, Principal Scientist and Lab Head in immuno-oncology, Vitry-sur-Seine, France

AI in Healthcare Stories

We are building and deploying AI-based solutions across our value chain responsibly, empowering our people with innovative technology, from research and development to manufacturing and patient engagement, to accelerate delivery to patients.

In the Spotlight

A man and a woman in a modern office space, looking at a computer screen. Copyright: Fabien Malot

February 24, 2026

AI Across the R&D Value Chain: Portfolio Decision-Making

Two scientists in a manufacturing setting looking at a digital display with a purple data wave depicting AI.

January 13, 2026

AI Across the R&D Value Chain: Manufacturing - Digital Labs and Self-Sharpening Tools 

Conceptual image depicting a human face with AI enhancement.

September 4, 2025

AI Across the R&D Value Chain: Clinical Development

Scientist working in a lab with purple wave digital overlay

July 9, 2025

AI Across the R&D Value Chain: Drug Discovery


All Our AI in Healthcare Stories

Year

February 24, 2026

AI Across the R&D Value Chain: Portfolio Decision-Making

January 13, 2026

AI Across the R&D Value Chain: Manufacturing - Digital Labs and Self-Sharpening Tools 

October 8, 2025

Modulus: Redefining the Future of Biopharma Manufacturing

October 7, 2025

How Sanofi is Rewriting the Script for Untreated Rare Diseases

September 4, 2025

AI Across the R&D Value Chain: Clinical Development

July 9, 2025

AI Across the R&D Value Chain: Drug Discovery

June 19, 2025

Digital and AI Powered Manufacturing & Supply: Delivering Faster and Safer for Patients

May 28, 2025

A New Era of Biopharma Production with AI

May 15, 2025

Data. Digital. Debate: How Sanofi is Transforming Regulatory Affairs